Clinical trial
Pilot Study of 89Zr Panitumumab in Pancreas Cancer
NCT04833959 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Study of 89Zr Panitumumab in Pancreas Cancer
- Lead sponsor
- Stanford University
- Phase
- Phase 1
- Overall status
- Withdrawn
- Start date
- March 26, 2021
- Completion date
- March 31, 2024
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pancreas cancer